Showing results (401-410 of 491) with videos related to
Sort By:
Pageof 50
Bone Marrow Transplantation|April 28, 2022
CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosisMariam T Nawas, Jeong-Ok Lee, Jessica Flynn, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2011
T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignanciesAnn A Jakubowski, Trudy N Small, Nancy A Kernan, et al.Clinical Therapeutics|March 9, 2010
Pharmacodynamics and pharmacokinetics of single doses of prasugrel 30 mg and clopidogrel 300 mg in healthy Chinese and white volunteers: an open-label trialDavid S Small, Christopher D Payne, Prajakti Kothare, et al.Clinical and Vaccine Immunology : CVI|March 9, 2006
FoxA2 involvement in suppression of protein C, an outcome predictor in experimental sepsisDavid T Berg, Bruce Gerlitz, Ganesh R Sharma, et al.Blood|August 25, 2007
T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulinAnn A Jakubowski, Trudy N Small, James W Young, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 24, 2017
T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic MalignanciesAnn A Jakubowski, Erica Petrlik, Molly Maloy, et al.Journal of the American Heart Association|November 6, 2016
Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary SyndromesJan H Cornel, E Magnus Ohman, Benjamin Neely, et al.Journal of the American College of Cardiology|February 27, 2016
Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus ClopidogrelJacob A Doll, Megan L Neely, Matthew T Roe, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 12, 2017
Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute LeukemiaBartlomiej M Getta, Mikhail Roshal, Junting Zheng, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 10, 2013
A phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with B cell lymphoid malignancies: favorably durable event-free survival in chemosensitive patientsCraig S Sauter, Juliet N Barker, Lauren Lechner, et al.Pageof 50